SCHEMBL6063695

SCHEMBL6063695

CC(C)CC(C(=O)NC(CCc1ccccc1)C(=O)c1nc(C(=O)N(C)c2cccc3ccccc23)co1)N(Cc1ccccc1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 2/20 0.38
PSMB5 P28074 3/20 0.35
CTSL P07711 4/20 0.35
CTSB P07858 3/20 0.35
CTSS P25774 2/20 0.35
CTSK P43235 2/20 0.35
KMT2A Q03164 1/20 0.35
F7 P08709 1/20 0.34
MMP8 P22894 3/20 0.34
METAP2 P50579 1/20 0.34
METAP1 P53582 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6463673 0.85 CTSL (0.46) CTSLCTSBCTSSCTSK
SCHEMBL7529171 0.84 DAGLA (0.40) DAGLAKMT2AMETAP2METAP1KDM4E
SCHEMBL6063863 0.84 NFKB1 (0.41) PSMB5CTSLCTSBCTSSCTSK
SCHEMBL6063413 0.73 CTSL (0.50) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL6464780 0.71 CTSB (0.42) DAGLAPSMB5CTSLCTSBCTSS
SCHEMBL6062904 0.70 CTSL (0.50) CTSLCTSBCTSSCTSK
SCHEMBL6466269 0.70 MMP9 (0.44) PSMB5CTSLCTSBCTSSCTSK
SCHEMBL6464783 0.70 MMP9 (0.44) PSMB5CTSLCTSBCTSSCTSK
SCHEMBL6466271 0.70 MMP9 (0.44) PSMB5CTSLCTSBCTSSCTSK
SCHEMBL6463671 0.69 REN (0.47) CTSLCTSBCTSSCTSKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed